http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
조종연,정종수 한국재난정보학회 2023 한국재난정보학회 학술대회 Vol.2023 No.11
본 논문에서는 「재외국민보호를 위한 영사조력법」이 시행됨으로써 자국민의 안전 복지 증대를 뒷받침하기 위한 재외국민 보호 전문인력 양성 필요성에 맞추어 재외국민보호 전문인력 양성 방안을 중점으로 연구하였다. 재외국민보호 전문인력은 먼저 재외국민보호 분야와 해외재난 분야에 관한 내용을 전문적으로 배워야 한다. 이러한 사항을 중점으로 한 전문인력의 운영 방안을 제시하였다.
ISO 22398과 HSEEP에 기반한 안전한국훈련 모델의 개선방안 연구
조종연,정종수 한국재난정보학회 2023 한국재난정보학회 학술대회 Vol.2023 No.11
본 논문에서는 안전한국훈련의 체계적은 포괄적 훈련 프로세스 모델을 개발하기 위해 국제표준인 ISO 22398과 미국의 국토 안보훈련(Homeland Security Exercise and Evaluation Program, HSEEP)의 훈련 모델에 기반해 국내 안전훈련을 위한 훈련 모 델을 개발하였다. ISO 22398에서는 훈련 프로그램, 훈련 프로젝트, 그리고 지속적 개선을 통한 환류 구조를 제시하고 있었고, 미국의 국토안보훈련에서는 대비 순환과 훈련 순환 구조를 서로 엮는 것으로 포괄적인 훈련 환류 구조를 완성하였다. 한국의 안전훈련이 연속성을 가지기 위해서는 두 훈련 모델을 통합해 지속적으로 환류지속이 가능한 훈련 모델의 개발이 필요해 이를 제시하였다.
기능연속성계획과 재해경감활동계획의 일원화를 위한 기업재난관리표준의 개선 방안에 대한 연구
조종연,정종수 한국재난정보학회 2023 한국재난정보학회 학술대회 Vol.2023 No.11
본 논문에서는 「재난 및 안전관리기본법」에서 국가 및 지방자치단체를 대상으로 의무적으로 세우는 “기능연속성계획”과 「재해경감을 위한 기업의 자율활동 지원에 관한 법률」에서 기업을 대상으로 자율적으로 수립하고 있는 “재해경감활동계획”에 대한 일원화를 위한 「기업재난관리표준」에 대한 개정안의 구성체계를 제시하고자 한다. 이를 위해 현행 「기업재난관리표준」의 미비점들을 도출하고, 해당 미비점을 바탕으로 「기업재난관리표준」의 목차에 대한 사전적 개정안을 도출하였다.
각종 암환자 69례에 대한 항암단의 항전이 및 재발억제효과
이용연,송기철,최병렬,서상훈,조정효,이연월,손창규,조종관,유화승,Lee, Yong-Yeon,Song, Kee-Cheol,Choi, Byung-Lyul,Seo, Sang-Hoon,Cho, Jung-Hyo,Lee, Yeon-Weol,Son, Chang-Gue,Cho, Chong-Kwan,Yoo, Hwa-Seung 대한한방내과학회 2002 大韓韓方內科學會誌 Vol.23 No.2
Purpose : Among numerous biological symptoms of cancer, matrix metalloproteinases (MMPs) are essential for tumor invasion and metastasis. HAD is used as an inhibitor of MMP gene. This study was designed to evaluate the effects of HAD on anti metastasis and preventing recurrence in cancer patients. Materials and Methods : We retrospectively analyzed the medical records of 69 cancer patients who had been administered with HAD for over 12 months continuously in East-West Cancer Center of Oriental Hospital of Daejeon University, from January 1993 to May 2002. Results : We analyzed gender, portion, stage and anti-metastasis & recurrence rates of cancer patients. Analysis of sex cases showed that the percentage of male is 62.3%, female is 37.7%. Analysis of cancer portion showed that the percentage of stomach is 31.9%, colorectum is 26.1%, lung is 21.7%, liver is 8.7%, breast is 8.7% Analysis of stage showed that the rate of III is 78.3%, IV is 13.0% and II is 8.7%. Analysis of anti-metastasis and recurrence rates showed that colorectal cancer is 77.8%, stomach cancer is 63.6%, lung cancer is 33.4% and breast cancer is 33.3% (mean : 53.6%). Conclusions : HAD has significant effects on anti-metastasis and preventing recurrence of tumor on cancer patients. So it helps to prolong the survival rates of cancer patients.
이용연,조정효,이연월,손창규,조종관,황규정,유화승,Lee, Yong-Yeon,Cho, Jung-Hyo,Lee, Yeon-Weol,Son, Chang-Gue,Cho, Chong-Kwan,Hwang, Kyu-Jeong,Yoo, Hwa-Seung 대한약침학회 2001 Journal of pharmacopuncture Vol.4 No.3
Objective: The purpose of this study is to develop and activate anti-tumor herbal acupuncture for cancer patients in South Korea. Methods: We investigated some literatures on anti-tumor herbal acupuncture which is used in South Korea and China, and made diagrams. Results: The results are summarized as follows. Anti-tumor herbal acupuncture is one of the traditional oriental medical method which is effective for cancer patients. In domestic studies, most of herb materials are belong to action of cooling&detoxification(25.0%) and strengthening body resistance(46.4%) which are proved to have effects of anti-tumor, immune activation and preventing tumor. In China, point injection therapy are used for improving symptoms of cancer patients and hea1ing tumor. Also herbal intravenous injection is used for combination of chinese traditional and western cancer therapy and treating cancer patients variously. Conclusions: From the above results. it is expected that anti-tumor herbal acupuncture is useful to improve clinical symptoms and quality of life(QOL) of cancer patients. Also we must develop new progressive methods of point injection and herbal intravenous injection for treating cancer patients, and advance clinical studies and trials.
이용연,송기철,최병렬,서상훈,최우진,조정효,이연월,손창규,조종관,유화승,Lee, Yong-Yeon,Song, Kee-Cheol,Choi, Byung-Lyul,Seo, Sang-Hoon,Choi, Woo-Jin,Cho, Jung-Hyo,Lee, Yeon-Weol,Son, Chang-Gue,Cho, Chong-Kwan,Yoo, Hwa-Seung 대한한방내과학회 2001 大韓韓方內科學會誌 Vol.22 No.4
Objectives: The purpose of this study was to explore some new therapies to control clinical symptoms of patients with terminal cancer by using external applications. Methods: We investigated some literatures on the external applications for cancer patients and made diagrams. Results: The results are summarized as follows. External applications are one of the traditional oriental medical methods and these are effective for pain control, ascites & pleural effusion and palpitable mass. It has some characteristics which are simple, safe and popular, but we must pay attention carefully to allergic reaction and toxicity in using external applications. The therapeutic portion of external applications are decided by discipline of syndrome and disease differentiation, and the prescriptions are composed of antitumor herb medicines. Conclusions: From the above results, it is expected that external applications are useful to improve clinical symptoms and quality of life(QOL) for patients with terminal cancer who cannot intake foods or medicines.
이용연,서상훈,유화승,최우진,조정효,이연월,손창규,조종관 대한한방종양학회 2000 대한한방종양학회지 Vol.6 No.1
Climical studies were carried out 83 cases of patients with colorectal cancer treated bv Hangamdan(抗癌丹) from January lth 1998 to September 30th 2000. The results were summarized as follows; 1. Distribution of those attached by colorectal cancer, by sex, showed that Male is more then Female, by age, showed that the numbber of fifties is majorith. 2. distribution of diagnostic stage, in descending order; stage Ⅲ(53%, top), stagew Ⅵ(45.8%). 3. The effects of maintenance and improvement in the symptoms with traditional oriental therapy(83.3%) and combined treatment of westem and oriental therapy(92.1%)were boserved. The effects of the symptoms were as folows: diarrhea(37.3%),abdominal pain (25.3%), general body weakness(22.9%), nausea(20.5%) and etc. in orders. 4. Analysis of hematology attached by colorectal cancer, maintenance and increasing of WBC(89.9%), RBC(74.7%), Hgb(81.1%), Platelet(92.4%) were Observed. After taken Hangamdan, the satety of the liver and kidney were as follows; maintenance and decreasting of AST(85.9%), ALT(94.8%) , GTP(87.5%), Creatinine(90.9%) were observed. 5. of IL-12 and IFN-λ attached by colorectal cancer, increasing of IL-12(53.3%), IFN-λ(80%) were observedl. 6. Analysis of QOL attached by colorectal cancer, maintenance and improvement of combined treatment of western and oniental therapy(89.6%), traditional oriental therapy(83.3%) were observed. 7. Analysis of survival in patients with Ⅳ stage of colorectal cancer, above 7 months(18.4%), 12 months(65.8%). 8. Analysis of antitumor effects, maintenance of traditional oriental therapy(83.3%) and maintenance and improvement of combined treatment of western and oriental therapy(80.5%) were observed. Analysis of tumor marker attached by colorectal cancer, maintenance and decreasing of CEA(78.8%) were boserved 9. Analysis of curative valuation, maintenance and improvement of traditional oriental therapy(83.3%), combined treatment of westem and oriental therapy(72.7%) were observed.
항암단(抗癌丹)을 투여(投與)한 대장암(大腸癌) 환자(患者) 83례(例)에 대한 임상보고(臨床報告)
이용연,서상훈,유화승,최우진,조정효,이연월,손창규,조종관,Lee, Yong-Yeon,Seo, Sang-Hoon,Yoo, Hwa-Seung,Choi, Woo-Jin,Cho, Jung-Hyo,Lee, Yeon-Weol,Son, Chang-Kyu,Cho, Chong-Kwan 대한암한의학회 2000 大韓癌韓醫學會誌 Vol.6 No.1
Clinical studies were carried out 83 cases of patients with colorectal cancer treated by Hangamdan(抗癌丹) from January 1th 1998 to September 30th 2000. The results were summarized as follows; 1. Distribution of those attached by colorectal cancer, by sex, showed that Male is more then Female, by age, showed that the number of fifties is majority. 2. Distribution of diagnostic stage, in descending order; stage III(53%, top), stage IV(45.8%). 3. The effects of maintenance and improvement in the symptoms with traditional oriental therapy(83.3%) and combined treatment of western and oriental therapy(92.1%) were observed. The effects of the symptoms were as follows: diarrhea(37.3%), abdominal pain (25.3%), general body weakness(22.9%), nausea(20.5%) and etc. in orders. 4. Analysis of hematology attached by colorectal cancer, maintenance and increasing of WBC(89.9%), RBC(74.7%), Hgb(81.1%), Platelet(92.4%) were observed. After taken Hangamdan, the safety of the liver and kidney were as follows; maintenance and decreasing of AST(85.9%), ALT(94.8%), GTP(87.5%), Creatinine(90.9%) were observed. 5. of IL-12 and $IFN-\gammer$ attached by colorectal cancer, increasing of IL-12(53.3%), IFN-{\gammer}(80%)$) were observed. 6. Analysis of QOL attached by colorectal cancer, maintenance and improvement of combined treatment of western and oriental therapy(89.6%), traditional oriental therapy(83.3%) were observed. 7. Analysis of survival in patients with IV stage of colorectal cancer, above 7 months(18.4%), 12 months(65.8%). 8. Analysis of antitumor effects, maintenance of traditional oriental therapy(83.3%) and maintenance and improvement of combined treatment of western and oriental therapy(80.5%) were observed. Analysis of tumor marker attached by colorectal cancer, maintenance and decreasing of CEA(78.8%) were observed. 9. Analysis of curative valuation, maintenance and improvement of traditional oriental therapy(83.3%), combined treatment of western and oriental therapy(72.7%) were observed. From the above results, it is suggested that Hangamdan has significant effects of antitumor and immune activity, also could be usefully applied for colorectal cancer patients by combination with western therapy or alone.